Table 1 Association of lncG expression and clinicopathological features in CRC patients
Clinicopathological features | lncG expression | P value | |
|---|---|---|---|
Low (%) | High (%) | ||
Gender | |||
Male | 23(56.10) | 18(43.90) | 0.215 |
Female | 11(40.74) | 16(59.26) | |
Age | |||
< 60 | 8(38.10) | 13(61.90) | 0.189 |
≥ 60 | 26(55.32) | 21(44.68) | |
Tumor size (cm) | |||
< 4 | 14(40.00) | 21(60.00) | 0.089 |
≥ 4 | 20(60.61) | 13(39.39) | |
Lymphovascular invasion | |||
Absent | 21(41.17) | 30(58.82) | 0.012 |
Present | 13(76.47) | 4(23.53) | |
Differentiation | |||
Well-moderate | 24(53.33) | 21(46.67) | 0.442 |
Poor | 10(43.48) | 13(56.52) | |
Depth of invasion | |||
T1 + T2 | 11(35.48) | 20(64.52) | 0.028 |
T3 + T4 | 23(62.16) | 14(37.84) | |
Lymph node metastasis | |||
N0 | 11(37.93) | 18(62.07) | 0.086 |
N1-2 | 23(58.97) | 16(41.03) | |
distant metastasis | |||
M0 | 22(42.31) | 30(57.69) | 0.022 |
M1 | 12(75.00) | 4(25.00) | |
TNM stage | |||
I + II | 10(34.48) | 19(65.52) | 0.027 |
III + IV | 24(61.54) | 15(38.46) | |